Clinical Trial

Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma

Name: Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular Carcinoma — clinical trial record (NCT07315022)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 4

View on ClinicalTrials.gov →

Summary

To evaluate the effectiveness of the combination of hydrochloride hydromorphone and flurbiprofen ester for post-TACE intravenous patient-controlled intravenous analgesia (PCIA).

Trial Details

NCT Number	NCT07315022
Lead Sponsor	First Affiliated Hospital, Sun Yat-Sen University Collaborators: Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Jinshazhou Hospital of Guangzhou University of Chinese Medicine
Conditions	Enhanced Recovery After Surgery, Multimodal Analgesia, Real-world Study, Transarterial Chemoembolization
Enrollment	129 participants
Start Date	2024-08-01
Primary Completion	2025-08-30 (estimated)
Study Completion	2025-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-02